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This paper presents and critically discusses a vast array of evidence on the determinants of mortality
reductions in developing countries. We argue that increases in life expectancy between 1960 and 2000
were largely independent from improvements in income and nutrition. We then characterize the age
and cause of death profile of changes in mortality and ask what can be learned about the determinants
of these changes from the international evidence and from country-specific studies. Public health infrastructure,
immunization, targeted programs, and the spread of less palpable forms of knowledge all seem to have
been important factors. Much of the recent debate has revolved around antagonistic approaches, which
are not supported by the evidence discussed here. Finally, the paper suggests that the evolution of
health inequality across and within countries is intrinsically related to the process of diffusion of new





College Park, MD 20742
and NBER
soares@econ.umd.edu  1
1 Introduction: A Closer Look at Life Expectancy Changes 
The last century witnessed profound transformations in the living conditions faced by the 
vast majority of human beings. Income per capita in the world is estimated to have risen fivefold 
in the period from 1900 to 2000. Life expectancy at birth in developed countries rose from 
around 45 in end of the 19
th century to above 75 in 2000. For many developing countries, gains 
in life expectancy just in the forty-year interval between 1960 and 2000 were above 20 years (see 
Maddison, 2004, Keyfitz and Flieger, 1968, and World Bank, 2005). 
Traditionally, changes in health have been treated as intrinsically linked to income. 
Therefore, growth has been seen as the cause of improved health, through improved nutrition and 
higher demand for health services. Though this relation is clearly present, social scientists have 
become increasingly aware that this view gives an incomplete picture of reality. Several 
important dimensions of human welfare, including life expectancy, have become gradually 
dissociate from income. Figure 1 portrays the cross-country relationship between income per 
capita and life expectancy at birth in 1960, 1990 and 2000. At any point in time, there is a clear 
positive correlation between the two variables (expressed by the logarithmic curves fitted to the 
data). Nevertheless, the figure shows a positive shift in this relationship throughout the period. 
This phenomenon was first noticed by Preston (1975), and seems to be happening at least since 
1930. For constant levels of income, life expectancy has been rising, and particularly so for 
poorer countries. After 1990, the devastating effect of AIDS in Africa changed this trend for the 
very low income levels, and halted the shift that had been observed in the previous 50 years. 
This figure stresses the fact that a significant portion of the recent changes in life 
expectancy has been orthogonal to changes in income. It is also related to the distinct behavior of 
cross-country inequality in income and life expectancy observed in the post-war period. Table 1, 
reproduced here from Becker et al (2005), presents a series of inequality measures for income 
per capita and life expectancy at birth, for the years 1960, 1990, and 2000.These data, as 
previous research has found, show that, by any measure, there is no evidence of reduction in 
income inequality across countries up to the 1990’s. During the 1990’s, due mainly to the 
experiences of China and India, there is a significant reduction in the cross-country dispersion in 
income per capita (without these two countries, income inequality is stable between 1990 and 
2000). In the case of life expectancy, the evidence is diametrically opposite. By any measure, life   2
expectancy inequality declines substantially over the whole period, but the decline in health 
inequality is concentrated entirely between 1960 and 1990. After that, the effects of AIDS in 
Africa are felt, and inequality increases slightly between 1990 and 2000 (Vallin and Meslé, 2004 
and Ram, 2006 show that, excluding Sub-Saharan countries from the sample, there are 
significant reductions in life expectancy inequality also between 1990 and 2000).
1 
Figure 2 illustrates this point further by plotting the regression to the mean in life 
expectancy between 1960 and 2000 (change in life expectancy against life expectancy in 1960). 
During this forty-year period, countries starting with high life expectancy levels tended to gain 
less in terms of life expectancy than countries starting with low life expectancy. According the 
un-weighted regression line in Figure 2 (as opposed to the weighted results presented in Table 1), 
life expectancies 10 years higher in 1960 were associated, on average, with gains in life 
expectancy 1.5 year lower in the following 40 years. But the average relation over the entire 
period hides radical changes taking place within specific intervals. Figure 3 breaks down the 
regression to the mean observed in Figure 2 into periods between 1960 and 1990, and 1990 and 
2000. In the first period, regression to the mean was stronger and more homogeneously 
distributed than in Figure 2, while in the second period the trend was completely reversed. 
The destabilizing nature of the changes observed in the beginning of the 1990’s becomes 
even more obvious once we look at this same type of decomposition for five-year consecutive 
intervals (Figure 4). From 1960 up to the 1990’s, there is a striking stability in the relationship 
between initial life expectancy and the change in life expectancy observed in the following five 
years. This relation is characterized by a positive slope for very low levels of initial life 
expectancy (below fifty years), with higher initial life expectancy associated with higher gains in 
life expectancy. For initial life expectancy above intermediary levels, this relation becomes 
negative, and higher initial life expectancy is associated with lower life expectancy gains. The 
relation between initial life expectancy and gains in life expectancy in the following five years 
remains virtually identical in the thirty-year interval between 1960 and 1990. Given its dynamic 
nature, such a stable relationship necessarily implies regression to the mean in life expectancy 
over the long run. Together with the evidence from Table 1, we also know that this pattern ended 
                                                 
 
1 Both these trends have been noticed before in the literature. In relation to income, see, for example, Barro and 
Sala-i-Martin (1995), de la Fuente (1997), Mankiw, Romer, and Weil (1992), Quah (1996), Parente and Prescott 
(1993), and Sala-i-Martin (2002), and in relation to life expectancy, see Bourguignon and Morrison (2002), Goesling 
and Firebaugh (2004), Neumayer (2003), Sap and Smith (2002), Younger (2001), and Kenny (2005).   3
up translated into convergence and reduced life expectancy inequality between 1960 and 1990. 
As countries starting with low life expectancy moved from left to right over the horizontal axis, 
they eventually reached a period of very large gains that led to convergence toward higher levels 
of life expectancy. 
The stability of this relation over the thirty-year period in question suggests that a 
continuous and natural process of change was underway. Riley (2005a) highlights the puzzling 
stability and homogeneity of the process of mortality reductions in the post-war period, despite 
different patterns of access to water, sanitation, education, income, and housing across the 
various countries. Though by the mid 1980’s researchers expressed concerns about the 
possibility of a collapse in the trend of mortality declines in developing countries, most countries 
sustained substantial gains in life expectancy up to 1990 (Hill and Pebley, 1989 and Riley, 
2005a). In reality, apart from Eastern Europe and Sub-Saharan Africa, most countries experience 
substantial gains in life expectancy up to today (Riley, 2005a). Nevertheless, around 1990 and 
before all countries could fully benefit from the improvements, the emergence of AIDS and – to 
a much lesser extent – the institutional turmoil in post-communist countries, led to the collapse 
of the regression to the mean relationship that was kept untouched at least since 1960 (this point 
is explored in further detail by Ram, 2005 and 2006). The effect of AIDS on the cross-country 
behavior of life expectancy after 1990 is overwhelming, and it can be seen from the fact that all 
countries experiencing declines in life expectancy above 5 years in Figure 3(b) are countries 
under siege by the epidemic (Botswana, Lesotho, Namibia, Swaziland, South Africa, Zambia, 
and Zimbabwe; see Philipson and Soares, 2005). The effect of AIDS at the end of the 20
th 
century dwarves any other change observed in the period and completely destabilizes a 
regression to the mean relationship that seemed to be almost technological in nature. Though the 
importance of AIDS in this context is self evident, the specific determinants of the previous 
improvements in life expectancy in the developing world remain unknown. 
The goal of this paper is to discuss the determinants of the improvements in life 
expectancy observed in the developing world during the post war period. Recent estimates 
suggest that longevity has indeed been a quantitatively important component of the overall gains 
in welfare during the twentieth century, both within and across countries (see Cutler and 
Richardson, 1997, Nordhaus, 2003, and Murphy and Topel, 2003, Burström, Johannesson, and 
Diderichsen, 2003, and Becker et a., 2005). Therefore, understanding the determinants of these   4
changes has immediate implications for both research and policy. From a research perspective, 
pinning down the factors determining the observed reductions in mortality may shed light on the 
interactions between health, human capital, and income, and on their relative importance for the 
process of economic development and social change. From a policy perspective, it may help 
maximize the impact of future health interventions in countries that still lag behind in terms of 
health improvements. In particular, this knowledge may be fundamental in designing policies to 
rescue Sub-Saharan Africa from its present state.
2 
The structure of the remainder of the paper is outlined as follows. Section 2 summarizes a 
large body of evidence from different sources in order to draw a broad picture of the nature, age 
and cause of death profile of recent reductions in mortality in the developing world. Following, 
section 3 raises some theoretical considerations on the determinants of mortality that are 
suggested by this general picture. Sections 4 and 5 then present the empirical evidence currently 
available on the specific determinants of reductions in mortality. In particular, section 4 
discusses the aggregate evidence, paying attention to the determinants of the diffusion of health 
technologies and to cross-country correlates of mortality, while section 5 analyzes the micro-
evidence from region and country-specific studies. Finally, Section 6 concludes the paper by 
tying together its different parts and, drawing on the various pieces of evidence available, giving 
a wide-ranging interpretation of the process of mortality reductions across the world. 
 
2 The Pattern of Mortality Reductions in Developing Countries  
  As noticed in the introduction, a large part of the life expectancy gains experienced by 
developing countries in the post-war period seems to be unrelated to improvements in income or, 
more generally, material living conditions. In Latin America, for example, this is clearly 
exemplified by the experiences of Bolivia, Honduras, and Nicaragua, where modest – or even 
negative – economic growth was accompanied by gains in life expectancy at birth of the order of 
20 years. This is by no means a phenomenon restricted to Latin America. Figure 1 shows that, in 
a broad cross-section of countries, life expectancy has been increasing for constant levels of 
                                                 
 
2 Ezzati et al (2003), for example, estimate that 25% of all deaths in Sub-Saharan  Africa are caused by conditions 
for which effective interventions already exist (respiratory infections, diarrheal diseases, low birth weight and 
malaria), with an additional 9% due to AIDS.   5
income. In this section, we discuss the nature of recent changes in mortality and analyze their 
profile in terms of age and cause of death. 
2.1 Nature of Mortality Changes 
  The shift in the income-life expectancy profile observed at least since 1930 does not 
imply the absence of a relationship between income and mortality. In reality, Figure 1 shows 
precisely that at any point in time there is a close positive association between income per capita 
and life expectancy at birth. This relationship reflects to a great extent differential nutrition and 
consumption of health services across different income levels. The role of income in determining 
mortality, mainly through nutrition, was extensively discussed by Fogel (see, for example, Fogel, 
1994 and 2004). His highly controversial analysis tends to attribute an extremely large fraction 
of the reductions in mortality to improved nutrition. But even so, he claims that nutrition 
explains almost all the mortality reductions in some European countries up to the end of the 19
th 
century, but only 50% after that. Starting in the beginning of the 20
th century, even according to 
Fogel’s extreme calculations, roughly half of the changes in mortality cannot be accounted for by 
improved nutrition, and seem to come from sources unrelated to improved material conditions. 
This is also what Figure 1 reveals. Though nutrition and consumption of health services imply a 
positive relation between income and life expectancy, some type of technological change has 
taken place, so that for constant income life expectancy has been rising. 
  Evidence from developing countries also supports the idea that the shift in the income-
life expectancy profile is not an artifact of improved nutrition for constant levels of income. 
Table 2, reproduced from Preston (1980, p.305), contains information on life expectancy at birth 
in 1940 and 1970, for countries at different income and nutrition levels. Life expectancy gains 
took place in all the nutrition brackets shown in the table. For the lowest nutrition group (less 
than 2,100 calories daily), there was an increase of 10 years in life expectancy at birth. Recent 
data also confirms this same pattern for the period between 1960 and 2000. Figure 5 first shows 
that, for constant levels of income, nutrition does seem to have improved slightly in the last forty 
years (as measured by daily caloric consumption). This may be the result of rising agricultural 
production and declining relative price of food. But the shift in the cross-sectional relationship is 
rather modest: typically, for constant income, calorie consumption increased by little more than 
200 kcal a day. This is far from enough to explain the shift in the income-life expectancy profile, 
as becomes clear in Figure 6. This figure shows that, between 1960 and 2000, the cross-sectional   6
relationship between nutrition and life expectancy at birth shifted in much the same way as the 
cross-sectional relationship between income and life expectancy. Between 1960 and 1990, for 
constant nutritional levels, life expectancy at birth raised by as much as 8 years for countries in 
the lowest caloric consumption range. After 1990, with the arrival of AIDS, the outward shift 
observed since 1960 was partially reversed, but still the relationship remained considerably 
above its initial profile.
3 
With a cross-country econometric analysis relating life expectancy improvements to 
income and caloric consumption, Preston (1980) concludes that approximately 50% of the 
changes in life expectancy between 1940 and 1970 were due to “structural factors,” unrelated to 
economic development or nutrition. Though this number is similar to the one obtained by Fogel 
(1994), Preston (1980) hypothesizes that income per capita also captures dimensions related to 
the provision of public health infrastructure, which are not present in Fogel’s framework. 
Heuveline (2001) extends Preston’s (1980) analysis and finds similar results for the period 
between 1960 and 2000.
4 
  Other evidence also supports the idea that improvements in nutrition and income are 
insufficient to explain the gains in mortality observed in recent decades. Palloni and Hill (1997), 
for example, analyze the pattern and extent of mortality changes in Latin America between 1950 
and 1990. Though concluding that mortality does respond to short term economic crisis (mainly 
among children, and from diarrhea and tuberculosis), they show that these responses are very 
small and quantitatively irrelevant when compared to the historical trend (though morbidity 
changes may be substantial). Caldwell (1986) discusses particular historical experiences of 
“mortality breakthroughs” that were not accompanied by similar economic growth, while Hill 
and Pebley (1989), Easterling (1996), Deaton (2004), and Cutler et al (2006), among others, 
present other types of arguments, all concluding that the relation between economic growth, 
nutrition, and mortality is far from enough to explain the improvements in life expectancy 
observed during the 20
th century. 
                                                 
 
3 The basic profile of the shift in these curves does not depend on the functional forms adopted. Logarithmic curves 
would lead to qualitatively similar results. 
4 In reality, as discussed by Mosley (1984), infection can hinder absorption of nutrients, being under certain 
circumstances a cause rather than a consequence of malnutrition. Obviously, the interaction between these two 
dimensions is complex, with each one reinforcing the other.   7
  In order to better understand this pattern of gains in life expectancy, we first explore in 
more detail the profile of changes in age and cause of death and how it relates to the process of 
reductions in mortality. 
2.2 Age and Cause of Death 
Changes in the age and cause-distribution of mortality characterize the progression of the 
demographic transition or, similarly, what has been termed the “epidemiological transition.” The 
term epidemiological transition was first coined by Omran (1971), as a description of the process 
of change in leading causes of death that takes place as mortality reductions progress, from 
infectious diseases to chronic non-transmissible diseases (see discussion in Riley, 2001). 
Associated with this change in leading causes of death, there is also a shift in the age-distribution 
of deaths, from mostly concentrated at younger ages to older ages, and eventually to a 
distribution where child and infant mortalities become relatively unimportant.
5 
This process of transformation has been widely documented in the now developed world, 
for cases where long-term mortality data are available. Preston and Haines (1991), for example, 
analyze changes in child mortality in the US around the end of the 19
th century. They show that, 
between ages 0 and 4, infectious diseases of the gastro-intestinal and respiratory tracts were 
responsible for 45% of all deaths, with premature birth, malformation, and childhood diseases 
accounting for an additional 30%. Improvements in the period were driven mainly by practices 
introduced with the acceptance of the germ theory of disease, including boiling milk and 
sterilizing bottles, washing hand before handling food, isolating sick family members, etc. This 
marked the initial stages of the evolution towards the systematic improvements in life 
expectancy observed during the 20
th century. 
Cutler and Meara (2001) complement this analysis by discussing the changes in the cause 
and age distribution of mortality in the US throughout the 20
th century. They show that during 
the first half of the century infectious diseases were the leading cause of death. During this 
period, nutrition and public health interventions were the most important factors determining 
reductions in mortality, and these reductions were mostly concentrated on mortality from 
infectious diseases at younger ages (80% of the life expectancy gains concentrated before age 45, 
                                                 
 
5 Today, the sequence of events described by Omran (1971) is not regarded as fixed, but rather as a consequence of 
technological advances taking place at different moments in history. Nevertheless, since it does give an accurate 
description of events in the historical experiences of mortality reduction discussed in this section, we keep his 
definition for now and save discussion on its merits to later on (section 6).    8
and roughly 65% concentrated before age 14; reduced deaths from infectious diseases were 
responsible for three-quarters of the gains in life expectancy in the period). 
Between 1940 and 1960, infectious diseases continued to play an important role, but 
specific medical innovations (mainly antibiotics) became important factors in determining 
mortality reductions. In this period, mortality changes were more evenly distributed across the 
different age groups and were strongly concentrated in diseases for which new drugs became 
available. 
Finally, in the period between 1960 and 1990, mortality reductions shifted towards more 
sophisticated and technologically intensive medical advances. These were concentrated on 
reduced mortality from heart and circulatory diseases at older ages and on mortality due to low 
birth weight at earlier ages. In this last period, changes in mortality above age 45 accounted for 
two-thirds of the overall gain in life expectancy.
6 
These authors show that major reductions in mortality from infectious diseases started 
taking place well before specific medical treatments became available. This is in line with the 
evidence presented by Cutler and Miller (2005), who estimate that the introduction of clean 
water technologies was responsible for 43% of the reductions in mortality observed in major 
American cities between 1900 and 1936. For infant mortality alone clean water is estimated to 
have been responsible for 74% of the reductions in mortality, and for typhoid fever, near 
complete eradication. Their particular point estimates should be regarded with caution, since the 
authors use lagged dependent variables together with fixed effects, leading to inconsistent 
estimates. But, nevertheless, their descriptive analysis and discussion gives strong support to the 
role played by the introduction of clean water in the reduction of mortality across large American 
cities, as also suggested by Easterlin (1996). In addition, they present evidence indicating that 
poorer populations benefited more from clean water systems than richer population, even though 
they were not the first group affected by it, therefore stressing the public good dimension of 
public health technologies. 
Historical evidence from England tells a similar story. McKeown and Record (1962) 
discuss the causes of death behind the improvements in life expectancy observed in England and 
                                                 
 
6 Reductions in adult mortality can be also caused by previous reductions in child mortality and morbidity, in 
addition to specific medical innovations. For example, heart problems in adulthood may be associated to childhood 
rheumatic fever. In this sense, part of the reductions in adult mortality observed during the later stages of the 
epidemiological transition may be just dynamic implications of early improvements in child health.   9
Wales between 1837 and 1900. They conclude that tuberculosis was responsible for 45% of the 
mortality reduction, while typhus and typhoid fever (22%), scarlet fever (19%), cholera, 
dysentery and diarrhea (8%), and smallpox (6%) were also important sources of life expectancy 
improvements. Though McKeown (1976) eventually defended the idea that nutrition was the 
main determinant of susceptibility to diseases and, therefore, that improvement in living 
conditions was the key determinant of mortality reductions, his first interpretation gave more 
credit to public policy. For typhus, typhoid fever and cholera, he initially conjectured that 
reductions in mortality were mostly due to sanitary reforms, while for scarlet fever they might 
had been affected by a change in the interaction between infectious agent and human host. The 
effect of direct treatment of diseases on overall mortality was relatively small, given that explicit 
therapies did not exist but for smallpox.
7 In the case of tuberculosis, there was no precise cause 
identified for the improvements in mortality. Since changes in the interaction between bacillus 
and men were unlikely in this case (men had been exposed to it for centuries), McKeown and 
Record (1962) concluded that most of the mortality reductions related to tuberculosis should be 
attributed to improving living conditions, mainly through improved diet. Overall, they argued 
that living conditions probably contributed roughly 50% for the total reduction in mortality in the 
period (tuberculosis and some effect on typhus and typhoid fever), while sanitary reforms were 
responsible for other 25% (most of reductions through typhus, typhoid fever, and cholera). 
Following chronologically, Livi-Bacci (2001) discusses the determinants of mortality in 
England from the end of the 19
th century until 1951. Over this period, England gained more than 
26 years in life expectancy at birth. Roughly 55% of these gains can be attributed to reductions in 
mortality due to infectious diseases, bronchitis, pneumonia, and influenza, with diseases of the 
infancy, diarrhea, and enteritis being responsible for other 13% (p.96).  
In the case of Italy, gains of 30 years in life expectancy at birth were registered between 
the end of the 19
th century and the middle of the 20
th century. As in England, roughly 55% of 
these gains can be attributed to reductions in mortality from infectious diseases, bronchitis, 
pneumonia, and influenza, with other diseases of the infancy, diarrhea, and enteritis being 
responsible for other 18%. By 1981, Italy had already shown substantial reductions in mortality 
                                                 
 
7 Edward Jenner developed a vaccine for smallpox in 1796, after when incidence of infection in Europe declined. 
The decline was somewhat uneven though, because of problems with vaccination and because the immunity lasted 
for about ten years only. The vaccine consisted of the subcutaneous inoculation of patients with the milder cowpox 
virus.   10
throughout the entire age distribution, with the probability of survival from birth to age 15 
increasing from 58% in 1881 to 98% in 1981, survival to age 50 increasing from 41% to 94%, 
and survival to age 80 increasing from 6% to 42% (Livi-Bacci, 2001, p.113). 
The well-documented historical experience of developed countries sheds light on the 
potentially important forces behind the changes observed in developing countries, even when 
these forces cannot be directly observed. In addition, it hints at the path that may lay ahead 
(despite concerns related to the abusive use of this view raised by Palloni, 1981). As long as we 
can characterize the reductions in mortality in terms of underlying causes of death or age groups, 
and the technologies available at a given point in time, the evidence discussed above will suggest 
the possible candidates for main determinants of mortality reductions. 
In this respect, the first significant effort to identify the diseases responsible for mortality 
reductions in the developing world was undertaken by Preston (1980). Table 3 (reproduced from 
Preston, 1980) presents the approximate percentage of mortality decline in less developed 
countries between 1900 and 1970 accounted for by different diseases. Preston argues that, apart 
from influenza/pneumonia/bronchitis, preventive measures were probably the most effective 
ones in determining mortality reductions. Large-scale immunization of populations and 
improvements of water supply and sewage disposal took place in several less developed 
countries throughout the second half of the twentieth century. The author argues that the direct 
impact of economic development in reducing mortality probably operated mostly through 
influenza/pneumonia/bronchitis, for which there was no effective deployment of preventive 
measures and treatment only became widely available later on in the period. For infectious and 
diarrheal diseases, improvements came through development of water supply, sewerage, and 
immunization (Preston, 1980, p. 313). Preston’s (1980) interpretation considers public health 
infrastructure (water and sanitation) as part of the process of economic development and, 
therefore, does not include it in what he calls “structural factors.” The table suggests that this 
view generates numbers similar to the income-nutrition-mortality analysis, with roughly 50% of 
the life expectancy gains being unrelated to simple improvements in material conditions 
(incidentally, this result is also similar to that of Fogel’s, 1994, even though the exercises are not 
strictly comparable; Fogel considers only the role of nutrition, while Preston, 1980 considers that 
development refers to income, nutrition, and improvements in health infrastructure).   11
Palloni and Wyrick (1981) find similar evidence for the case of Latin America between 
1955 and 1973. They show that reductions in mortality due to infectious diseases, 
influenza/pneumonia/bronchitis, and diarrhea were the main factors contributing to the gains in 
life expectancy observed in the period. Factors unrelated to living standards seem to have been 
particularly important in regions where malaria was endemic, and where other infectious 
diseases were more prevalent. In line with the results mentioned above, they find that 55% of the 
reductions in mortality were due to exogenous factors, while only 45% came from improvements 
in living standards. 
The relation between changes in mortality by cause of death and methods of prevention 
and treatment portrayed in Table 3, and discussed in the previous paragraphs, is similar to that 
suggested by Cutler and Meara (2001). In general, changes in mortality by cause of death are 
also intimately linked to changes in mortality by age of death, reflecting the epidemiological 
stage of development of a specific society (see Palloni, 1981). At a point in time, both of these 
will be related to the type of health technology available and employed in each particular case. In 
this sense, the historical pattern observed in developed countries mirrors the cross-country 
differences in mortality changes observed in the post-war period. Mortality reductions 
experienced by developing regions in the last 40 years are very similar to the ones experienced 
by the US in the beginning of the 20
th century, while the ones experienced by developed regions 
look very much like the ones experienced by the US in recent years. 
  Table 4, calculated from the results presented in Becker et al (2005), illustrates this point. 
These results refer to the period between 1965 and 1995, and are based on a relatively small 
sample (49 countries), so that they are only representative of middle-range developing and 
developed countries. The table shows how the pattern of cause and age-specific life expectancy 
gains changes across different development levels (Sub-Saharan Africa and South Asia are 
absent from the sample). In the poorest region (Middle East and North Africa), life expectancy 
gains are almost entirely concentrated on infectious diseases of the respiratory and digestive 
tract, and congenital anomalies and perinatal period conditions. As a result, 90% of the mortality 
reductions are concentrated before age 19. As the development level increases, mortality shifts 
monotonically from early to old ages (following, in order, Latin America and the Caribbean, East 
Asia and the Pacific, Europe and Central Asia, and North America). In the case of North   12
America, 60% of the mortality reductions are attributed to heart and circulatory diseases and 
nervous systems and senses organs conditions, all concentrated above age 50. 
  Both the within country historical trends in mortality, and the cross-country variation in 
life expectancy gains, suggest a process of mortality reductions that describes the progression of 
a country through the different stages of the epidemiological transition. Nevertheless, there is no 
agreement as to the specific factors that determined these reductions. Following, we raise some 
theoretical considerations suggested by the stylized facts discussed in this section and confront it 
with the evidence currently available on the specific determinants of mortality reductions in 
developing countries. 
 
3 Theoretical Considerations 
  The evidence discussed in the previous sections suggests that “structural factors,” not 
directly related to economic development, were responsible for a substantial fraction of the 
recent reductions in mortality in developing countries. Still, a question that remains open is 
exactly what these “structural factors” were. Since significant reductions in mortality took place 
at very low income levels and with minimal expenditures on health, it is believed that diffusion 
of new technologies (maybe incorporated in ideas, personal health practices and public goods) 
must have played an important role. 
  It may therefore be tempting to draw on the well-established trade literature on 
international diffusion of productive technologies in order to guide the discussion on the 
determinants of mortality reductions (for an extensive review of this literature, see Keller, 2004). 
A central idea in the trade literature is that technology is embodied in goods. Therefore, when a 
country imports a capital good from a technology-generating center, it immediately becomes 
more productive, since the new capital good incorporates a more efficient technology and its use 
reflects that. In this case, improved productivity is simply a result of the use of a better 
intermediate good, not necessarily implying the understanding of this new technology or the 
capacity to reproduce it on the part of the user (importing country). In addition, this literature 
stresses the possibility that researchers in a given country may benefit from the R&D generated 
elsewhere, through increases in the stock of knowledge available in society. Of course, the 
possibility of this second mechanism rests on the nature of the R&D in foreign countries (non-
excludable) and on the capacity of the home country to access and “absorb” this new knowledge.   13
  Though the diffusion of productive technologies may indeed offer some insights into the 
process of diffusion of health technologies, there are key aspects of the latter that are somewhat 
specific to it. First, to a great extent, health is the outcome of a household production process. 
This is true in terms of household behaviors related to personal hygiene, handling and 
preparation of food, treatment of water, and handling of these same issues in raising offspring. In 
this perspective, absorption of technology demands absorption of knowledge on the part of the 
consumer/producer herself. This aspect is probably more important at low levels of income (or 
high levels of mortality), so that the idea of embodiment of new technologies in goods purchased 
on the market is likely to be relatively unimportant in these cases. As health improvements 
become more dependent on specific medical interventions, as in the examples cited by Deaton 
(2004), the relative importance of the “embodied technology” idea is therefore likely to increase. 
This would probably take place mainly through the imports of medicines and medical equipment, 
both of which may incorporate new technologies leading to higher productivity in terms of health 
outcomes. 
  A second specific aspect is the fact that health technologies have a large public good 
dimension. Basic ideas and knowledge, in particular, are extreme versions of this notion. For 
example, as soon as the germ theory became widely accepted, its main implications became 
publicly available to agents who had the capacity to absorb them. In reality, this is the most 
extreme version of a real public good, where the idea itself is literally non-excludable, non-rival, 
and not subject to any type of congestion.
8 In typical health technologies, however, this is not the 
case. But externalities and traditional public goods are still very important when discussing, 
among other things, the development of new medicines and the implementation of public health 
programs. Particularly, several public health programs are implemented precisely because private 
provision is not viable or inefficient. This is the case in relation to the provision of clean water 
and sewerage systems, vaccination campaigns, environmental regulations, etc. In some of these 
examples, technologies are not particularly sophisticated and goods do not incorporate new 
                                                 
 
8 Mokyr (1998) discusses the process of advances in knowledge in medical sciences and the technological 
innovations induced by it. In another paper, Mokyr (2000) discusses in detail the final acceptance of the germ theory 
in the end of the 19
th century, and the implications it had in terms of changes in personal and public health practices. 
He also points to the fact that the beginning of the health revolution, related to the early recognition of “cleanliness” 
as a way to prevent diseases, dates back to the empirically based sanitary and hygienic movement from the early 19
th 
century, well before the advent of the germ theory.    14
knowledge, but implementation involves large fixed costs and very low marginal costs, and is the 
outcome of an intricate political process that is affected by many other considerations. In other 
examples, goods do incorporate new technologies, but their adoption still depends on the 
outcome of a centralized political process. In any case, changes depend on processes that are 
outside the control of any individual agent in society and that, given its political and 
technological nature, may be exogenous even to the economic conditions faced by the country. 
  Easterlin (1996 and 1999) stresses arguments along similar lines in order to draw a 
distinction between innovations in health technologies and in productive technologies. He 
suggests that the profit motive is not enough to lead to technological investments in health 
improvements, as opposed to technological investments in productive technologies. Because of 
that, mortality reductions in the past were not due exclusively to market forces. Externalities, 
public goods, principal-agent, and free rider problems plague the nature of investments and 
interventions related to health, and therefore government action or centralized provision are 
required for efficiency to be achieved. In some cases, efficient government action requires actual 
overriding of property rights and personal freedoms, such as in compulsory immunizations, 
sanitary reforms in slums, or sacrifice of animals due to risk of contamination (tuberculosis-
infected cows in the historical example, or avian flu-infected birds in recent years). The 
importance of political action, together with institutional ability and willingness to implement 
known technologies, is also highlighted by Mosley (1984) and Cutler et al (2006). 
  For all these reasons, it is likely that the diffusion of health technologies depends much 
more on the absorption of knowledge on the part of agents and on public provision, and less on 
the embodiment of new technologies, than does the diffusion of productive technologies. This is 
particularly important for changes in mortality observed at very low levels of development, when 
improvements can take place even with very low expenditures on health. This logic opens space 
for reductions in mortality independently of improvements in income, as observed in the 
historical examples, but still leaves room for several alternative mechanisms through which this 
change could take place. Candidate mechanisms in this respect range from diffusion of pure non-
rival and non-excludable knowledge, to public or international interventions focused at particular 
diseases, or to family and community health programs targeted at health practices within the 
household.   15
  In relation to the diffusion of knowledge, one of the most dramatic events of the last 
century was the acceptance of the germ theory (developed on the turn of the nineteenth to the 
twentieth century), which allowed for inexpensive gains in life expectancy via simple preventive 
measures (see Vacher, 1979, Ram and Schultz, 1979, Preston, 1980 and 1996, and Ruzicka and 
Hansluwka, 1982, Easterlin, 1999, and Mokyr 2000). Simple changes on public practices and 
personal health behavior, brought about by knowledge previously inexistent, allowed for 
significant reductions in mortality rates at relatively low costs (Preston, 1996). These new 
technologies came in the form of both changes in personal practices and large scale 
interventions. In this context, the role played by developed countries in information 
dissemination and program implementation is thought to have been particularly important. 
Health programs became increasingly dissociate of countries’ economic conditions, and more 
dependent on the concerns of the developed world. Even though the monetary value of the help 
was typically small, the largest contribution came in the form of development of low cost health 
measures, training of personnel, initiation of programs, and more effective and specific 
interventions (see Preston, 1980, and Ruzicka and Hansluwka, 1982). 
  International mobilization was also important in determining the possibility and 
effectiveness of the fight against specific conditions and diseases. One of the most celebrated 
examples in this respect is the United Nations’ Expanded Program on Immunization (EPI). The 
EPI was implemented in 1974 with the goal of bringing previously available vaccines against 
various diseases (measles, diphtheria, pertussis, tetanus, tuberculosis, and polio, among others) to 
the disadvantaged population of developing countries. In countries reached by the program, 
immunization rates skyrocketed in a matter of few years, while infection rates dropped 
immediately. Among other things, the EPI reached virtual eradication of polio from the 
Americas in 1994, and raised immunization rates for the six target diseases mentioned above 
from 5% of the world’s newborns in 1974 to more than 80% in 2000 (WHO, 2003 and World 
Bank, 2005). Country specific interventions focused particularly on endemic conditions and on 
public health infrastructure were also successful, as exemplified by the case of malaria in 
Guyana, Guatemala, Mauritius, Mexico, Sri Lanka, and Venezuela (see Gray, 1974).  
  Still, the potential importance of community and family level interventions should not be 
minimized. In reality, the presumed importance of these factors led some researchers to raise 
concerns about the effectiveness of narrow interventions focused on the delivery of specific   16
technologies (see, for example, Mosley, 1984, or discussion in Hill and Pebley, 1989). Their 
main objection was that, for example, vaccination for one disease might simply increase 
mortality by competing causes of death for immediate later ages, having therefore a relatively 
modest impact on overall life expectancy. According to this view, immunization or the use of 
“palliative measures” (as rehydration therapy) would just postpone the death of a child, and 
increase mortality by other causes. An adequate health intervention would therefore require a 
broader approach to the problem, taking into account the social factors conditioning mortality in 
different communities. In practical terms, this line of reasoning highlights the relevance of 
maternal education and household production as determinants of child mortality, and the 
importance of community-level interventions focused on the provision of comprehensive 
primary care. In addition, it stresses the cultural dimension as a key determinant of the success of 
any program (Mosley, 1984). 
  Taking into account these different candidates for determinants of reductions in mortality, 
the next sections look at the evidence currently available from both cross and within country 
perspectives. 
 
4 International Evidence 
4.1 Aggregate Patterns 
  In order to clarify the pattern of changes hidden behind the life expectancy gains in 
developing countries, Table 5 presents age-specific mortality rates by regions of the world. The 
table presents mortality rates before ages 1 and 5 (per 1,000 live births), and between ages 15 
and 60 (per 1,000 adults), for the years 1960 and 2000. 
  The mortality data used here are from the World Bank’s World Development Indicators. 
Health related data presented in the World Development Indicators are from the United Nations 
Statistics Division’s Population and Vital Statistics Report, from national statistical offices, from 
the Demographic and Health Surveys, or from UNICEF. A word of caution is in place here. 
Though most of the primary vital statistics used in these calculations come from national civil 
registration systems, the degree of coverage and information detail of the systems may vary 
substantially from country to country. When these statistics are not available or are incomplete, 
periodic surveys, projections, and censuses are used to complement the data (United Nations, 
2005). Most importantly, detailed age specific mortality rates are not always available and   17
indirect estimations based on auxiliary data or demographic models are oftentimes used. This is 
not a major concern in relation to child and infant mortality, for which estimation based on 
survey data on number of children ever born and number of children alive give quite accurate 
estimates (Brass, 1975), but it can be a problem for mortality at older ages. In these cases, 
absence of data is usually overcome by the use of model life tables. Model life tables allow the 
estimation of mortality rates at adult and old ages based on the observation of a few age specific 
mortality numbers, and on the classification of a given population within one specific “family” 
of model life tables (United Nations, 1983). Though the use of indirect data in the comparison 
and analysis of health changes has been strongly criticized by some researchers (Musgrove, 
2003), others have argued that it is an integral part of the process of evolution in the 
measurement of health systems performance, and it reflects the best use of the information and 
knowledge currently available (Brutland et al, 2003). Other public health researchers have also 
highlighted the importance of analyzing various dimensions of health performance, not only 
child and infant mortality, even  if only with the limited existing information, in order to draw an 
adequate picture of the health status of different populations (Mathers et al, 2003a, Mathers et al, 
2003b, and Bruntland et al, 2003). 
  Even though the application of model life tables to estimate mortality rates at certain ages 
may lead to inaccurate measures for one particular country, we believe that its use does not 
systematically bias the estimates and, thus, produces on average good descriptions of the 
mortality profiles observed in the world today. Keeping this limitation in mind, we look at the 
mortality numbers presented by the World Development Indicators as reasonable approximations 
to the average patterns of mortality observed in different regions of the world. 
  In Table 5, we see that, in developing areas, reductions in mortality were significant in 
every age group, though they were more extreme for infant and child mortalities. In Latin 
America, mortality before age 1 was reduced by 70% between 1960 and 2000, while mortality 
before age 5 was reduced by almost 80%. At the same time, the probability of dying between 
ages 15 and 60 fell from 0.27 to 0.17, corresponding to a 35% reduction in adult mortality. In 
East Asia and the Pacific, mortalities before ages 1 and 5 were reduced by, respectively, 77% 
and 80%, while adult mortality declined by 73%. Middle East and North Africa, together with 
South Asia, also experienced substantial mortality reductions in all age groups, though typically 
attaining levels somewhat higher by year 2000. The only exception to this pattern is the case of   18
Sub-Saharan Africa, where reductions in infant and child mortality were more modest (both 
around 32%), and reductions in adult mortality non-existent (mainly due to the effects of AIDS 
starting in the early 1990’s). 
  Apart from the case of Sub-Saharan Africa, the trends observed in developing countries 
reflect the movement from the first stages of mortality reductions, when infant and child 
mortalities are the most important factors, to the second stage, when adult mortality becomes 
relatively more important. This can be partly inferred from the regional differences seen in the 
table. While developed areas (North America and Europe) start in 1960 already with levels of 
child mortality considerably low, the poorest areas (Sub-Saharan Africa) do not experience 
significant reductions in adult mortality up to the end of the period. In between, we have Latin 
America and the Caribbean, East Asia and the Pacific and, lagging a little behind, South Asia, all 
of which experienced significant declines in both adult and child mortalities.
9 
  Within regions, differences in trends across countries can also be significant. In Latin 
America, for example, there are cases such as Guyana, Paraguay and Uruguay, where reductions 
in adult mortality have been relatively minor when compared to changes in infant and child 
mortalities. At the same time, in Chile, Costa Rica, Cuba, Guatemala, Mexico, Panama and Peru, 
adult mortality was reduced by more than 50% over the forty-year interval portrayed in the table. 
The only increase in mortality in Latin America during the period is registered for adult mortality 
in Haiti, where the number goes from 401 per 1,000 adults to 449. 
  Overall, the idea that infant and child mortality reductions were virtually the only causes 
of life expectancy gains in developing countries is mistaken. Typically, mortality reductions took 
place across the entire age distribution, with significant improvements in the survival of both 
children and adults. Undoubtedly, the extent of reduction in early mortality was astounding, and 
its final effect on life expectancy was probably higher than that of changes in mortality in any 
other age group (see Table 4, for example). But, at the same time, the probability of surviving 
from age 15 to age 60 increased between 10 and 45 percentage points across most of the 
developing world, and the extent of this change cannot be ignored. 
                                                 
 
9 Adult mortality for Europe and Central Asia increases slightly between 1960 and 2000 due to the presence of some 
former communist countries in the sample. In these countries, the collapse of the Soviet Union was associated with 
significant increases in adult and old age mortality. If we look to Western Europe alone, reductions in mortality were 
also substantial between ages 15 and 60.   19
  The analogy with the evidence from developed countries suggests that, in the post-war 
period, the developing world was in the transition between the first and second phases of the 
epidemiological transition. This corresponds to large reductions in mortality from infectious 
diseases at early ages, but already significant gains in life expectancy from other causes of death 
at later ages. The source and extent of the reductions in infant and child mortalities in this period 
(see Tables 4 and 5) suggests changes very similar to the ones observed in the US during the first 
half of the 20
th century. In that case, reductions in mortality were driven mainly by preventive 
public health interventions related to the provision of clean water (Cutler and Meara, 2001 and 
Cutler and Miller, 2005). But this was a consequence of the simple fact that, for most infectious 
diseases, alternative technologies – such as immunization or treatment (antibiotics) – were not 
yet widely available. In the case of developing countries in the post-war period, these 
technologies were already available and, in some cases, were actively subsidized or even directly 
implemented by international organizations (as in the example of the Expanded Program on 
Immunization discussed before). Some international programs, on the other hand, also provided 
aid for implementation of clean water systems, as the econometric evidence discussed later on 
addresses. So it is likely that a mixture of preventive and treatment factors – identified as 
important in, respectively, the first (1900-1940) and second (1940-1960) phases of the US 
experience – played important roles in the changes observed in developing countries between 
1960 and 2000. 
  Tables 6 and 7 present a series of variables measuring different dimensions of health 
expenditures, infrastructure, and inputs for regions of the world. The information in the table is 
typically available for periods much shorter than the ones for which we have mortality data. The 
data from the World Development Indicators used here come mostly from the World Health 
Organization. Public expenditure data are complemented with information from the Organization 
for Economic Cooperation and Development, the International Monetary Fund, and the World 
Bank itself. Data on private expenditure in developing countries, on the other hand, are drawn 
largely from household surveys conducted by governments and international organizations. 
Information on physicians and hospital beds also use data from OECD, TransMONEE, and from 
individual countries. Finally, immunization data is complemented with information from 
UNICEF and from the Demographic and Health Surveys (World Bank, 2005).   20
  The shortcomings related to data quality mentioned before are potentially even more 
serious in cases such as immunization coverage, and hospital and physician availability. For 
number of physicians per capita and hospital beds, for example, definitions may vary 
substantially across countries and sources. The effort of developing a comparable set of metrics 
to evaluate and contrast the performance of health systems across countries and regions is a 
relatively new one, and this ends up reflected in the quality of the statistics currently available 
(Mathers et al, 2003a). For example, in the case of immunization, Murray et al (2003) show that 
the cross-country correlation coefficient between officially reported rates and rates calculated 
from the Demographic and Health Surveys (DHS) is only 0.45 (for DPT3 coverage in 41 
countries, between 1985 and 1998). And, even though the coefficient of a regression of the 
officially reported rate on the DHS rate is 1.02, the constant term is equal to 0.21, indicating that 
official rates overestimate coverage rates by, on average, 20%. They also show that this relation 
seems to be non-linear, with countries with lower coverage having official and DHS rates more 
closely related than countries with high coverage (where the overestimation in official rates is 
larger). More seriously, there is no clear pattern on the association between official and DHS 
rates when changes over a 5 year-period are analyzed (regression coefficient of 0.21, with R
2 
equal to 0.02). Since different countries and periods of time in the World Development Indicators 
are covered by different sources, a detailed analysis of this type of problem in the current dataset 
would require an effort beyond the scope of this paper. Therefore, we follow on our discussion 
based on the data tabulated by the World Bank (2005), but keep in mind this limitation. In the 
next section, we analyze micro evidence from country-level studies to evaluate whether the 
conclusions suggested by this anecdotal evidence seem to be robust. 
  Table 6 shows that private expenditures on health in developing regions have increased, 
on average, on par with income, so that the GDP percentage has remained roughly stable (with 
the exception of East Asia and the Pacific). Public expenditures have shown a modest positive 
trend, leading to an increase in total expenditures on health between 0.5% and 1.3% of the GDP 
between 1990 and 2000. As fractions of GDP, these are levels way below the ones observed in 
the developed world, and quantitatively correspond to considerably low values (below $300, as 
measured in 1996 international prices). Therefore, it is difficult to think that increases in 
expenditure would be the only underlying reason behind the changes in mortality rates (in 
reality, the shift in the income-life expectancy profile indicates that it is not).   21
  Direct access to hospitals and medical services do not seem to be important factors either. 
The table shows that, if anything, the availability of hospital beds per inhabitants has been 
decreasing in most regions of the world. This reduction probably reflects the advent of new 
health technologies, rather than a widespread deterioration in the provision of medical services. 
The physically limiting aspect of many chronic conditions, as well as the recovery period of 
surgical interventions, may have been significantly reduced due to the availability of new drugs 
and, in some cases, reduced prevalence due to other technological innovations. In addition, the 
number of painful or fatal diseases for which no treatment was available and hospitalization was 
the only alternative may also have decreased. Therefore, technological innovations are likely to 
have generally shifted medical interventions away from continuous medical supervision in 
hospitals and toward more punctual and technologically intensive care. 
  The factors in Table 6 that seem potentially important in explaining the gains in health in 
developing countries are access to improved sanitation and treated water (measured as 
percentage of the population). Both of these have experienced increases between 5 and 12 
percentage points in East Asia and the Pacific, Middle East and North Africa, Latin America and 
the Caribbean, and South Asia, in the short period of time between 1990 and 2000. These are 
changes encompassing more than 5% of the population in the regions in a period of only 10 
years. Though data are not available, it is not difficult to imagine that changes along these 
dimensions must have been very significant between 1960 and 1990 and that these may have 
played an important role in the mortality reductions in the period. Some casual observations 
support this view. For example, the extreme outlier in terms of life expectancy in Latin America 
is also an extreme outlier in terms of access to improved sanitation and treated water (Haiti). In 
addition, some of the countries in that same region that experienced extremely large life 
expectancy gains with very little economic growth – such as Bolivia, Honduras, and Nicaragua – 
are precisely countries that had significant improvements in the public provision of these 
services. This evidence suggests that factors playing a role in the first stages of the US 
experience were also important in the recent experience of developing countries. 
  But evidence suggests that some other factors may also have been relevant. These are 
technologies related to large-scale immunizations, which were not available during the first half 
of the twentieth century and, therefore, could not have been responsible for the early mortality 
reductions in developed countries. The first two columns in Table 7 present data on   22
immunization rates for DPT and measles between 1980 and 2000, measured as the percentage of 
children below one year of age receiving the respective vaccine. The extent of changes registered 
in the table is striking. In this twenty-year period, the average immunization rates in East Asia 
and the Pacific, Middle East and North Africa, and Latin America and the Caribbean jumped 
from levels around 40% to close to 90%. South Asia and Sub-Saharan Africa also presented 
significant improvements along these dimension, though at a much slower pace than other 
regions. Even accounting for the bias discussed by Murray et al (2003), these numbers still imply 
an increase of almost 100% in immunization rates. In several specific countries, at least one of 
the immunization rates increased by more than 50 percentage points in this twenty-year interval. 
As of year 2000, the averages observed in these developing regions were extremely close to the 
ones observed in the developed world. Again, despite the unavailability of data, it is not difficult 
to imagine that similar improvements were observed between 1960 and 2000, in which case 
immunization rates would have changed from arbitrarily low levels in the immediate post-war to 
close to 90% by the turn of the century. 
  The fact that the United Nations Expanded Program on Immunization was established 
only in 1974 suggests that this view is probably accurate. This program subsidized large scale 
immunization of several different diseases and transferred immunization technologies to 
developing countries, leading, among other things, to virtual eradication of poliomyelitis in the 
Americas. The worldwide immunization rate (children under one) for the six diseases that 
originally constituted the main target of the program – tuberculosis, diphtheria, neonatal tetanus, 
whooping cough, poliomyelitis, and measles – is estimated to have risen from 5% in 1974 to 
80% today. The choice of target diseases itself had the explicit goal of maximizing impact, 
giving priority to diseases that had a high burden and for which there were well-tried vaccines 
available at low costs (World Health Organization, 2003, World Bank, 2003). In the case of the 
Americas, the Pan American Health Organization created the “Revolving Fund for Vaccine 
Procurement,” which subsidized the purchase of vaccines by member countries, leading to 
savings that, in some circumstances, amounted to 80% of the price of vaccines (de Quadros et al, 
1998). 
  In the case of immunization, casual observation also suggests that it is a potentially 
important factor in explaining the mortality reductions observed between 1960 and 2000. Again, 
the country with an exceptionally poor performance in terms of life expectancy in Latin America   23
and the Caribbean (Haiti) is precisely the one that lags way behind the rest of the region in 
immunization rates. And countries experiencing exceptional gains in life expectancy without 
significant improvements in income also experienced exceptional increases in immunization 
rates (for Bolivia, Honduras, and Nicaragua both immunization rates increased by at least 57 
percentage points in only 20 years). 
  These factors are likely to play a particularly important role in the reduction of child 
mortality. But, in principle, reductions in child mortality may also have other determinants, such 
as improved nutrition of children and mother. Table 7 shows that this does not seem to be the 
case. Though malnutrition prevalence (for children under 5) shows some reduction in East Asia 
and the Pacific, South Asia, and, more moderately, in Latin America and the Caribbean, it 
increases slightly in the Middle East and North Africa and in Sub-Saharan Africa. During this 
period, Middle East and North Africa experienced spectacular reductions in child mortality, with 
the mortality rate under the age of 5 dropping from 252 per 1,000 live births in 1960 to 50 in 
2000. The same type of evidence can be seen from the experience of specific countries in other 
regions. For example, in Nicaragua and Honduras, where mortality under the age of 5 was 
reduced from around 200 to 40, the prevalence of malnutrition actually increased. Other 
dimensions directly related to nutrition within the family also do not seem to be particularly 
relevant during this period. To the extent that these factors end up reflected in the birth weight of 
the child, the data do not show any consistent improvement. In reality, the percentage of low 
birth weight babies remained stable or increased slightly in most regions of the world between 
1980 and 1995. This probably reflects, to a great extent, improvements in medical sciences in 
dealing with problematic pregnancies, which end up reflected in a higher percentage of fragile 
babies surviving birth. But, nevertheless, this implies a compositional change in the pool of 
children surviving birth that, if anything, would on itself imply increased mortality in the first 
years of life. 
  Therefore, the aggregate evidence suggests that, apart from income, two factors are 
strong candidates for determinants of the life expectancy gains observed in developing countries 
since World War II. Large-scale immunizations and improved public health infrastructure may 
have been among the key factors determining the reductions in mortality observed during the last 
40 years. We now move to a discussion of the limited statistical evidence available regarding the   24
role of these factors, as well as that of technological diffusion, in determining recent changes in 
mortality. 
4.2 Cross-Country Correlates 
  Despite the limitations suggested in section 3, recent econometric attempts to identify the 
determinants of cross-country mortality changes drew heavily on the trade literature on 
international diffusion of productive technologies (Keller, 2004). Maybe because of immediate 
data availability, the majority of econometric studies has focused on the transfer of technology 
through imports of goods. Jamison et al (2001), Owen and Wu (2004), and Papageorgiou et al 
(2006) find that imports and, more generally, openness to trade are associated with faster 
reductions in mortality. All these authors develop arguments along the lines of the literature on 
diffusion of productive technologies, but they are not always able to deal convincingly with 
endogeneity and identification issues, and leave open the possibility that trade variables are 
actually capturing the effects of other policies or unobservable variables.
10 Owen and Wu (2004), 
in particular, find a strong correlation between trade and mortality for developing countries, 
while the correlation is virtually zero for rich countries. Given the arguments developed in the 
previous paragraph, it is not clear that this should be the case. They also present some evidence 
on other important factors: higher rates of immunization (DPT and measles), higher amounts of 
aid per capita targeted to water improvement, and higher female schooling are all systematically 
associated with lower mortality. 
  In respect to the effect of trade itself, Jamison et al (2001) notice that, when the analysis 
does not control for openness, countries with difficult access to the outside world (landlocked) 
and countries in tropical areas are found to experience smaller improvements in life expectancy. 
To the extent that these variables are related to access to trade and to the adaptability of imported 
technologies for local production of health, this tends to make the results more credible. If trade 
is indeed capturing the incorporation of technologies produced in developed areas, countries with 
difficult access to trade or with different environments should benefit less from new 
technologies. 
                                                 
 
10 “Good governments” may implement good economic and social policies. Good economic policies may lead to 
openness, while good social policies may lead to reductions in mortality. This would generate a correlation between 
openness and mortality in the data, even thought there would be no causal relationship between the two variables.   25
  The results related to trade are also somewhat more convincing in the case of 
Papageorgiou et al (2006), who measure the relevance of imports in a more sophisticated and 
adequate way. They focus particularly on medical imports originating from the ten countries 
responsible for the bulk of medical R&D in the world. In a series of different specifications, they 
find these imports to be systematically related to lower mortality. They also find that female 
schooling, caloric intake, and physician availability are significantly correlated with the cross-
country variation in mortality.   
  The relevance of medical technologies, specifically in what refers to new drugs, is further 
supported by the evidence discussed in Lichtenberg (2003). In a sample of 50 countries including 
only upper-middle level developing and developed countries, he shows that the launch of new 
drugs (new chemical entities) between 1986 and 2000 had a strong positive impact on the 
probability of survival. He claims that these new drugs were responsible for 40% of the gains in 
life expectancy observed in the sample during the period. 
  Schultz (1993), on his turn, analyzes the role of other types of cross-country determinants 
of mortality between 1972 and 1988. He finds that caloric consumption and maternal education 
were the variables most closely related to mortality, with number of physicians, supply of water 
and sanitation not playing statistically significant roles. The results related to female education 
are in line with those found by Owen and Wu (2004), but other results related to public health 
infrastructure and access to health facilities contradict some of the later evidence. In any case, 
endogeneity and omitted variables remain open issues in most of the cross-country literature and 
no study dealt with all of their implications in a convincing way.  
  As a whole, this evidence indicates that new technologies incorporated in medical goods 
and medicines do seem to be important in determining gains in life expectancy. But it is likely 
that these dimensions are relatively less important for poor developing countries, where 
reductions in mortality have been observed even with very low expenditures directly targeted to 
health consumption. In this direction, the cross-country evidence offers some very preliminary 
indication that other factors, such as schooling and provision of public health goods, may also 
have been relevant. In order to shed further light on the role played by these factors, the next 
section discusses the micro-level evidence available from developing countries. This evidence 
also allows us to uncover the role of country specific interventions and community-level   26
programs for which aggregate data are not available (such as anti-malaria campaigns and family 
health programs). 
 
5 Micro-Evidence from Developing Countries 
There is a large array of demographic literature on within country variations in mortality. 
Most of this literature concentrates on the analysis of infant and child mortality, for which 
demographic techniques based on retrospective surveys on number of children ever born and 
number of children alive give quite accurate estimates. Two major strands of papers can be 
identified: the first one analyzes the impact of particular interventions, events, or health 
programs; and the second one looks at correlates of within-country variations in mortality. In this 
section, we selectively review some results from both strands of literature. 
On the evaluation of particular health interventions, Gray (1974) is an early example of 
analyses of the impact of malaria control measures. Gray (1974) evaluates the contribution of 
malaria control to the post-war mortality decline observed in Ceylon (current Sri Lanka). Starting 
in 1945, commercial supplies of DDT became available and a more effective control of malaria 
in Ceylon started taking place. This led to an elimination of the mortality differential previously 
existent between endemic and non-endemic areas, and to fast declines in national mortality rates. 
According to the estimates, malaria control contributed with 23% of the observed reduction in 
the crude death rate during the post-war period (up to 1960). In the initial control period (1946-
1950), malaria elimination is estimated to have contributed with roughly 1/3 of the total 
mortality decline (particularly relevant for children below age 5 and adults above 45). Gray 
(1974) also mentions similar results obtained in studies of other malaria control programs 
(Guyana, Guatemala, Mexico, Venezuela, and Mauritius). Nevertheless, Langford (1996) argues 
that these numbers are likely to be somewhat overestimated, and suggests that DDT alone was 
probably responsible for no more than 16% of the reduction in mortality in the post-war period. 
He points to the fact that other anti-malarial measures and improvements in public health were 
observed before the 1940’s, and are also likely to have played some role in the reductions in 
mortality observed immediately after the war. 
Lincoln et al (1983), on their turn, analyze the effect of family planning, tetanus vaccine, 
and oral rehydration therapy. They look at data from sixteen years of operation of the 
International Centre for Diarrheal Disease Research (Matlab Thana, Bangladesh, between 1966   27
and 1981). During this period, there were several changes introduced in the services provided to 
the target population. In some cases, randomized double-blind trials were also implemented. The 
results indicate that tetanus vaccine given to pregnant women reduced newborn 4-14 day 
mortality by 68% (tetanus was initially an extremely important cause of death among infants, 
accounting for 26.2% of deaths). Other therapies also appeared as important in reducing 
mortality, with a broad program of family planning being responsible for a 25% reduction in the 
crude death rate (half the decline in the period), and rehydration therapy for another 9%. 
Macinko et al (2006) also present evidence of significant effects of health programs 
targeted at the family and household level. They use state-level panel data from Brazil (1990-
2002) to evaluate the impact of a family health program on mortality. The program (Programa 
Saúde da Família) was largely based on preventive care, but evidence shows that family 
inclusion in the program also affected rates of breastfeeding and immunization, and improved 
maternal management of diarrhea and respiratory infections. The program was particularly 
effective in reducing deaths attributable to diarrhea. 
From a historical perspective, Díaz-Briquets (1981) discusses the evolution of mortality 
in Cuba (mainly Havana) between 1899 and 1953, when the country was subject to considerable 
American influence. Following the Spanish-American war, Cuba was occupied by the US for 
four years (between 1898 and 1902). After emancipation, the Platt Amendment gave the US right 
to intervene in Cuba’s internal affairs if certain conditions – such as sanitary improvements – 
were not met. US occupation instituted a series of sanitary reforms, leading to virtual elimination 
of yellow fever from the country (following the first verification of the mosquito theory of 
transmission), and reductions in mortality from tuberculosis and other infectious and parasitic 
diseases. Reduction in tuberculosis mortality seems to have been due initially to improvements in 
economic conditions and nutrition and, after the 1940’s, to the introduction of antibiotics. Other 
infectious and parasitic diseases were more directly affected by specific sanitary and public 
health measures: diphtheria mortality was reduced by the use antitoxin (freely distributed by 
national sanitation authorities); malaria due to anti-mosquito campaigns; and diarrhea, gastritis 
and enteritis due to extensive sanitary reforms in Havana (improved and more abundant water 
supply and public health efforts to teach proper infant care, accompanied by increases in literacy 
rates). Mortality by influenza, pneumonia, and bronchitis was reduced only after 1931, and 
mainly after 1943, so that the reduction must have been partly due to the use of modern drugs   28
(there was also a moderate previous decline, due to improvements in living conditions). McGuire 
and Frankel (2005), though recognizing the importance of education, urbanization and targeted 
health programs, highlight that improvements along these dimension occurred well before 1945, 
while a significant part of the progress in life expectancy in Cuba was observed only after that. 
Therefore, the authors argue that the role of access to health care for an exceptionally large 
fraction of the population (due to a large supply of doctors, small geographic size of the island 
and access to services by the urban poor) should not be underestimated. 
The role of education, sanitation, and access to water and medical services is also stressed 
in several within-country papers on child mortality. Haines and Avery (1982) analyze the 
experience of Costa Rica between 1940 and 1970, and try to disentangle the effects of education, 
income, sanitation, housing, and medical services. The authors conduct a cross-sectional analysis 
using census data (between 1968 and 1973) on the cantons of Costa Rica. They find that medical 
care (proportion of births having medical attention) had a substantial impact on child mortality 
independently of other variables (alone, accounted for 64% of the regional variation in infant 
mortality). From the perspective of changes through time, mother’s education, fertility and 
sanitation appeared as important factors associated with mortality reductions. Overall, 
development (as related to income per capita, literacy, and caloric consumption) accounted for 
50% of the mortality decline in Costa Rica between 1940 and 1970. McGuire (2001) shows that 
the trend of mortality declines continued in Costa Rica even after 1970 and argues that factors 
similar to those highlighted by Haines and Avery (1982) also played an important role in this 
later experience. Similarly, Haines et al (1983) use national samples of censuses from Guatemala 
(1959-1973) and conduct analyses on small geographic units (90 aggregations of municipalities) 
to show that women’s education and sanitation were the most important factors determining 
child mortality differences. Alves and Belluzzo (2004) find that education and sanitation were 
also the key determinants of changes in child mortality in the case of Brazil, between 1970 and 
2000. Their study analyzes Brazilian municipality data over a period when substantial reductions 
in child mortality took place.  
Evidence on the importance of access to clean water, again together with mother’s 
education, is presented by da Vanzo and Habicht (1986), Merrick (1985), and Macinko et al 
(2006). Using micro data from Malaysia between 1946 and 1975, da Vanzo and Habitch (1986) 
find that mother’s education and piped water were the factors most closely associated with child   29
mortality, while sanitation was also marginally relevant. Other social aspect that appears as an 
important determinant of mortality in the case of Malaysia is breast-feeding, which seemed to 
reduce the negative effect of lack of access to treated water. Merrick (1985) and Macinko et al 
(2006) find similar evidence for Brazil. Merrick (1985) uses census and household survey data 
between 1970 and 1976 to track down the effects of an extensive effort undertaken by the 
Brazilian government in the early 1970’s to improve urban environmental conditions 
(PLANASA), through better water supply and sanitation. He finds that parents’ education and 
access to piped water were the factors most closely related to child mortality both in 1970 and 
1976. Particularly, access to piped water explained about one-fifth of the regional differentials in 
child mortality. Macinko et al (2006), in their evaluation of the family health program discussed 
above, also show incidentally that access to water and female literacy were closely related to 
mortality. 
Jain (1985) analyzes data for the period between 1973 and 1978 in rural India, and shows 
that, together with mother’s literacy, type of birth attendant and triple vaccination were closely 
related to regional variations in child mortality. Breaking down child mortality in different 
periods of the child’s life, the author shows that poverty and medical care received at birth were 
particularly important for neo-natal mortality, while availability of medical facilities in the 
village and the extent of triple vaccination during infancy were most important for post-neo-natal 
mortality. 
In terms of within country studies, Caldwell (1986) takes a broader perspective and 
discusses several dimensions of economic, social, or public health changes that may have 
affected what he calls “breakthrough periods” of mortality reductions. He analyzes three 
historical experiences of exceptional declines in mortality – Kerala (India, 1956-1966), Sri Lanka 
(1946-1953), and Costa Rica (1970-1980) – and argues that these three experiences were also 
exceptional in their social and political environments, and in their effectiveness in providing 
inputs in the areas of education, health services, and nutrition. He particularly highlights the role 
of cultural factors – female autonomy, intrinsic value attached to education, open political 
system (competition), large civil society without rigid class structure, and national consensus 
related to policies – as important in allowing for the adoption of new health inputs and the 
absorption of new technologies. In this interpretation, education and a demanding public appear   30
as key factors in order for interventions to be implemented and to work. Also, as other evidence 
has shown, results did not depend on the use of particularly expensive technologies. 
In the case of Sri Lanka, cholera was contained starting in the 1870’s through quarantine 
measures (for arrivals from India) and later construction of a pipe water system, while neonatal 
tetanus was cut down by the systematic use of midwives. Starting in 1910, successful campaigns 
against diarrhea, respiratory infections, and hookworm disease (supported by the Rockefeller 
Foundation) stressed the need for public health, sanitation, and personal hygiene. Other 
important events included the malaria campaign started immediately after the war (led to nearly 
eradication at the time through the use of DDT spraying) and the popularization of penicillin and 
sulfa drugs. Health expenditures over this period never rose above 1.5% of GDP, despite a 
profound enhancement in public health infrastructure and programs (Caldwell, 1986). 
In the Indian state of Kerala, the mortality breakthrough took place between 1956 and 
1966. During this period, deaths from cholera and smallpox, which accounted for one-sixth of all 
deaths at the end of the 19
th century, were drastically reduced. After World War I, these causes 
of death never again accounted for more than 3% of all deaths. In this experience, extensions of 
public health programs and immunization – through provision of community level services – 
seem to have been the immediate cause for most of the mortality reductions. Similarly, Costa 
Rica increased expenditure on health services leading to a breakthrough period between 1970 
and 1980. As in Kerala, easy-access and community level services – coupled with immunization 
campaigns – were very important in reducing infant and child mortality (Caldwell, 1986). 
Riley (2005b) describes the experience of exceptional mortality reductions of Jamaica 
(life expectancy at birth above 75 years in 2000), and compares it to the three cases analyzed by 
Caldwell (1986). He argues that in Jamaica, as in Kerala, Sri Lanka, and Costa Rica, women 
have historically been more independent (though for different reasons), public schooling 
developed early, and there was a tradition of open and lively discussion of political and social 
issues. But, on the other hand, widespread corruption and organized crime have greatly 
undermined the institutional effect of political freedom. Also in Jamaica, substantial government 
investments in health and widespread use of the schooling system as a means of delivering 
public health education to the population – both dating back to British colonial times – seem to 
have been particularly important. School teachers were explicitly trained to be health educators, 
teaching people how to recognize and treat themselves against specific diseases and vectors.   31
Riley (2005b) concludes that reductions in mortality in Jamaica up to the end of the 20
th century 
were driven mostly by improvements in public health, individual behavior, and schooling. 
  It is clear from the discussion in previous paragraphs that the evidence from within 
country mortality studies is very diverse in nature, focus, and methodology. Nevertheless, it does 
address some concerns raised in the demographic literature, and also reveals some surprisingly 
consistent results. 
  First, evidence shows that interventions targeted at a particular set of diseases (be it 
malaria, tetanus, or diarrhea, for which there are 12 possible agents) have shown substantial and 
sustained success in reducing mortality. Therefore, concerns related to the possibility that narrow 
approaches focused on specific technologies end up simply increasing mortality from competing 
causes of death do not seem to be empirically relevant (Mosley, 1984 and Hill and Pebley, 
1989). In reality, Hill and Pebley (1989) discuss evidence from malaria and measles eradication 
programs in Guyana, Kenya, Sri Lanka, Tanzania, and Zaire that suggests exactly the opposite: 
in the implementation of targeted programs, overall reductions in mortality seem to be 
systematically larger than the direct reduction in the cause-specific mortality that constitutes the 
initial target. There seems to be synergistic benefits from reductions in mortality from one cause 
of death that end up reducing mortality also from other causes. This would be the case if, for 
example, one type of disease increased an individual’s probability of dying from another disease 
(due to weakened immune system or reduced capacity to absorb nutrients, as suggested by 
Mosley, 1984). Still, the evidence does support the idea that family health programs, 
implemented at the community level and taking into account the broader scope of social 
specificities facing the target population, can also be very effective in reducing mortality. This 
was the case with successful programs implemented in Bangladesh and Brazil, and also with 
some dimensions of the Jamaican experience. So, in general, there is no need for an a priori 
choice between disease-specific targeted interventions and broad interventions focused on health 
practices and the cultural context within the community or family. Evidence indicates that both 
strategies are potentially effective in reducing mortality. The ideal program in each particular 
case seems to be a function of the extent of mortality from endemic conditions for which specific 
interventions are available, as compared to the extent of mortality from causes that can be 
minimized through improvements in individual or collective health practices.   32
Second, in relation to the specific role played by different factors, there is an 
overwhelming amount of suggestive evidence pointing to the importance of education, 
particularly mother’s education, in determining infant and child mortality. Part of the association 
between these variables reflects the effect of income on health, but studies controlling for 
socioeconomic status still found robust correlations between mother’s education and child 
mortality. This relation, even if taken as a causal one, is not yet fully understood in the literature.  
Haines and Avery (1982) and Haines et al (1983) hypothesize that better educated mothers may 
seek medical care more actively, may be more aware of sanitary precautions, nutritional 
information, and health services, and may be better able to recognize serious child health 
conditions. Jain (1985) presents evidence in support of this view, showing that mother’s literacy 
improves the type of medical care used during birth and the use of preventive and curative 
measures during the post-neo-natal period. Nevertheless, other authors view the effect of 
schooling as being one of modernization and indoctrination of the target population (Caldwell, 
1986 and Riley, 2005b). According to this interpretation, schooling would familiarize the 
population with Western values and institutions, reducing their resistance to seeking medical 
attention or using modern medicines. Hobcraft (1993) reviews a vast array of evidence on the 
effect and the channels through which maternal education affects child mortality. He shows that 
educated mothers are better informed about and more likely to use medical facilities and other 
health technologies, are more likely to have their children immunized and to have received 
prenatal care, and are more likely to have their deliveries attended by trained personnel. At the 
same time, Hobcraft (1993) identifies some social aspects that may also intervene in the relation 
between maternal education and child mortality: educated mothers marry later and have fewer 
children, therefore tending to emphasize quality rather than quantity of children. Overall he 
identifies five channels linking mother’s education to child mortality, but is unable to quantify 
the relative importance of each one. These channels would include greater cleanliness among 
more educated women, increased utilization of health services, greater emphasis on child quality, 
and enhanced female empowerment (including an increased feeling of control over the outside 
world, more identification with modern institutions, greater individual confidence, and increased 
bargaining power within the family). 
The potential role of access to clean water and sanitation suggested by the aggregate data 
is also partially supported by the micro evidence. Different micro-studies tended to emphasize   33
one of these dimensions and, maybe due to a high degree of correlation between the two, have 
rarely been able to identify independent effects of both. But various papers cited here identify a 
significant correlation between either sanitation (Haines and Avery, 1982, Haines et al, 1983, 
and Alves and Belluzzo, 2004), or access to clean water (da Vanzo and Habicht, 1986, Merrick, 
1985, and Macinko et al, 2006), and mortality. Also, anecdotal evidence from Cuba and Kerala, 
among others, confirms the potential importance of factors linked to infrastructure in triggering 
successful experiences of mortality reduction. 
Overall, the evidence supports the effectiveness of specific interventions – such as 
malaria control programs, rehydration therapy, and immunization – in reducing mortality. It also 
indicates that family and educational health programs can improve individual and community 
level practices, reducing the probability of infections and improving health management. Finally, 
it highlights the importance of health infrastructure, through access to clean water and sanitation. 
Given the diverse methodological nature of the studies discussed, it is impossible, based solely 
on this evidence, to isolate the specific role of each different factor. 
 
6 Conclusion: Understanding Mortality Changes across and within Countries 
Bringing together the evidence on the evolution of life expectancy across countries and 
on the changes and correlates of mortality within countries can help us understand the 
determinants of mortality improvements and their implications for the evolution of health 
inequality. If we think about the recent process of global health improvement as one of 
discoveries, diffusion, and absorption of new ideas, technologies, and practices, this process will 
be mirrored by changes in the distribution of health outcomes across and within countries, 
according to the nature of the new technologies and their gradual transmission throughout the 
world. 
Studies based on micro data, by revealing the within country pattern of mortality 
inequality and its evolution through time, shed light on the nature of the technological changes 
driving the reduction in mortality. In this respect, Haines et al (1983) notice that mortality 
differentials (urban-rural, by educational level, etc) increased in Guatemala while mortality was 
reduced. In addition, the interaction of different dimensions seemed to enhance inequality, so 
that educational level tended to be more advantageous in the capital than elsewhere. Along the 
same lines, da Vanzo and Habitch (1986) found that the effect of mother’s education on child   34
mortality in Malaysia was increasing through time, while water and sanitation became less 
important. They also found evidence that the effect of mother’s education was particularly strong 
in more developed areas. 
Historical evidence from the US also suggests that the educational gradient of mortality 
has increased through time (Preston and Haines, 1991). In the end of the 19
th century, just before 
the germ theory of disease became widely accepted and applied, mortality differentials in the US 
across occupations or social classes were rather small. Professional and literate people had a 
minor advantage when compared to the rest of the population, and even children of doctors faced 
mortality rates that were only 6% below the national average. Already by 1925, children of 
teachers and doctors had mortality rates corresponding to only 65% of that from the average 
population, suggesting that progress and scientific knowledge tended to increase health 
inequalities along educational lines. Similarly, countries today at a development level 
comparable to that of the US in 1900 typically have higher life expectancies and steeper 
mortality-educational gradients than the US did at that time. 
But results related to the effect of development on health inequality are not consensual in 
the literature. Haines and Avery (1982), for example, find that education and urban residence 
were associated with lower mortality in Costa Rica, but that the educational gradient was higher 
in rural than urban areas, and that the urban mortality advantage disappeared for high levels of 
education. Similarly, they also find that the response of mortality to education was higher among 
women with low education, and tended to disappear as educational level increased. Merrick 
(1985) also finds similar evidence for Brazil. He shows that improved and increased water 
supply attenuated mortality differentials associated with education and income (effect of water 
stronger among low income groups). Macinko et al (2006), also for the case of Brazil, show that 
access to water and female literacy were particularly important determinants of mortality in the 
poorer regions of the country (North and Northeast), and that the effect of family health 
programs tended to be 3 times larger in these same regions. 
Still, there is a large amount of evidence indicating that within country mortality 
inequality may increase as average mortality is reduced. For the US, UK, and Western Europe, 
evidence suggests that health inequalities increased in recent years (Glied and Lleras-Muney, 
2003). For developing countries, in addition to the cases of Guatemala and Malaysia mentioned 
above, Minujin and Delamonica (2004) look at Demographic and Health Surveys from 18   35
developing countries and show that inequality in under-five mortality seems to have increased 
during the 1990’s in at least 8 of them (Bangladesh, Colombia, Dominican Republic, Indonesia, 
Kazakhstan, Philippines, Uganda, and Zimbabwe). 
Caldwell (1986) already hypothesized that development and technology might increase 
the educational gradient of mortality, but his argument – as well as that of more recent authors – 
seems to hinge on an implicit assumption about the nature of the technology being considered. 
Technologies related to individual-level inputs used in the production of health seem to be 
subject to the effectiveness with which individuals can use the inputs. Evidence indicates that 
more educated individuals have higher survival advantage in diseases for which medical progress 
has been particularly important, and that this advantage is greater for recent technologies (Glied 
and Lleras-Muney, 2003). More educated individuals are also more likely to use recently 
developed drugs, above all in situations where individuals repeatedly purchase the same drug, 
suggesting that education increases the capacity of individuals to learn from experience (Lleras-
Muney and Lichtenberg, 2002). Studies on the AIDS epidemic in Africa (Burkina Faso, 
Cameroon, Ghana, Kenya, Tanzania, and Uganda) suggest that schooling is closely related to the 
adoption of protective behaviors, such as use of condom, counseling and testing, and discussion 
among spouses; it also suggests that educated individuals are more responsive to information 
campaigns (de Walque, 2004 and 2006). Similar evidence on the role of maternal education in 
determining child mortality was discussed in the last section (see, for example, Hobcraft, 1993). 
New technologies associated with individual actions can therefore offer an advantage to the more 
educated, if they are better able to comprehend and adopt the technology. In these cases, 
diffusion of new technologies might increase mortality inequality within countries. 
But, on the other hand, technology adoption is sometimes also incorporated in public 
goods. In these cases, provision of a new technology may affect individual outcomes 
independently of individual actions (such as with clean air and water), and may in reality reduce 
the relevance of personal behavior in determining health status. The evidence presented on 
malaria control in Ceylon, family health programs in Brazil, and access to urban public health 
infrastructure in Costa Rica, Malaysia, and Brazil indicates that all these “technologies” seem to 
reduce the importance of individual behavior – and, therefore, individual characteristics – in 
determining health outcomes. In these cases, one would expect introduction of new technologies 
to be associated with reduced health inequality within countries.   36
Therefore, contrary to the case of cross-country mortality, it is difficult to state 
unequivocally what the effect of recent technological diffusion on within-country inequality has 
been. Based on the evidence discussed before, the impact of technology adoption on within-
country health inequality seems to depend on two dimensions: the character of the technology 
(private versus public) and its degree of diffusion. Diffusion of new private technologies whose 
use is still restricted to relatively small portions of the population are likely to lead to increasing 
inequality, as relatively more educated and well-off people benefit more from it. With time, as 
the private technology’s use becomes widespread throughout the population, inequality in health 
would then start being reduced. This sequence of events would mimic the process of 
international diffusion of medical technologies across countries, and reproduce its impact on the 
evolution of inequality. 
With public technologies, however, as long as all the population of a certain area can 
benefit from the public good, the effect should be in the direction of reducing mortality 
irrespective of individual characteristics, and maybe in some cases even reducing the effect of 
specific individual traits (such as education) on mortality. Still, in reality, adoption of public 
good technologies also varies within a country – across neighborhoods, cities, and states – and 
the timing of adoption may well depend on the political influence and organization of different 
groups. In this case, the effect of introduction of new technologies on inequality would also 
depend on its degree of penetration and on the level of analysis in question. Though introduction 
of clean water distribution systems may reduce health inequality between the wealthy and poor 
within a single city, it may increase inequality across different cities in the same country, as long 
as cities benefiting from the new system are initially better off. Across different levels of 
aggregation – from countries, through states and municipalities, to individuals – differential 
changes in inequality actually reveal the process of technological diffusion itself, and the nature 
of the technology being absorbed. 
The long term evolution of life expectancy inequality across countries is also intimately 
linked to this same pattern of technological innovation and diffusion. Despite the almost 
monotonic post-war trend towards reduced inequality, history has not always been the same. 
Bourguignon and Morrison (2002), for example, show that life expectancy inequality across 
countries increased consistently between 1820 and 1930, when then it started falling. Vallin and 
Meslé (2004) restrict the analysis to a group of 9 developed countries and show that, among   37
these countries, life expectancy inequality increased steadily between mid 18
th century and the 
turn of the 20
th century, when it also started falling to reach its lowest level in recent years. 
In line with the arguments developed above, Vallin and Meslé (2004) suggest that the 
idea of an epidemiological transition, characterized by a fixed sequence of events, is not the 
adequate concept to understand the improvements in life expectancy observed across-countries 
in the last two hundred years. They suggest that the pattern of evolution of life expectancy across 
countries, and therefore the evolution of life expectancy inequality, is driven by new knowledge 
and by the gradual process of absorption of this new knowledge by different societies. Typically, 
as new knowledge emerges and some countries take advantage of the technologies implied by it, 
health inequality would increase reflecting the differential access to the new benefits across 
countries. If the technology became accessible to a large number of countries, its subsequent 
widespread diffusion would eventually lead to reduced inequality. Absorption capacity across 
different countries would then depend on the nature of the technology itself, and on institutional 
aspects of the country, as related to its infrastructure, provision of health public goods, and 
political responsiveness. 
This is a paradigm based on the dynamics of technological shocks and their international 
diffusion, which would have speed and penetration dependent on the specific type of technology 
and on the characteristics of the different countries. Vallin and Meslé (2004) call it a “health 
transition,” as opposed to the term “epidemiological transition” made famous by Omran (1971). 
They identify three such technological shocks that marked the dynamics of health inequality 
throughout the 20
th century: the conquest of mortality from infectious diseases, which was 
characterized as an epidemiological transition by Omran (1971) and is still diffusing throughout 
the developing world; the cardiovascular revolution, which started in the mid 1960’s and is still 
mostly restricted to the developed world; and a potential progress against mortality at very old 
ages taking place right now and benefiting only a handful of countries. Associated with each one 
of these breakthroughs there would be an initial period of increasing inequality, as only few 
leading countries took advantage of the initial progress. Following, if the technology spread 
through other parts of the world, there could be a reduction in inequality. This sequence of events 
is close to completion in what refers to infectious diseases, where the initial increase in 
international health inequality in the 19
th century was followed by a reduction in inequality 
starting in the mid 20
th century. With cardiovascular diseases, we would still be observing a   38
period of increasing international inequality, as shown by the evidence presented in Becker et al 
(2005) and the discussion in Vallin and Meslé (2004). Finally, regarding the fight against aging, 
this process would still be at its initial stages, with very few leading countries taking advantage 
of the new technologies (Vallin and Meslé, 2004). 
Based on the evidence discussed above, the consequence of these waves of technological 
diffusion to mortality reductions and inequality within countries would depend on the nature of 
the technologies and on the within country pattern of geographical diffusion. But it is not 
difficult to imagine that patterns similar to those observed across countries would emerge across 
different regions of the same country, as more developed areas were better able to initially take 
advantage of certain types of technological improvements. At the same time, broad health 
projects – taking place at the national scale – would probably lead to more homogenous 
reductions in mortality and to instantaneous reductions in overall health inequality (national 
immunization or anti-malaria campaigns, for example). Still, the recent waves of technological 
advance – related to cardiovascular diseases and aging – seem to be more closely related to 
private health technologies than the breakthroughs in the fight against infectious diseases. 
Reductions in mortality from cardiovascular diseases require radical changes in personal 
behavior and expensive medical interventions. These seem to have, in nature, much less of 
public goods than do some of the early technologies associated with reductions in mortality from 
infectious diseases (provision of clean water and sanitation, immunization campaigns, anti-
malaria campaigns, and even provision of basic education). Therefore, one may wonder that, 
once the conquest of mortality from infectious diseases is complete in most of the developing 
world, diffusion of the second and third waves of the health transition will be accompanied by a 
long period of rising life expectancy inequality, both within and across countries. 
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Figure 1: The Changing Relationship between Income and Life Expectancy; 1960, 1990, and 2000
1960: life = -37.9 + 11.7*ln(inc)
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Figure 2: Cross-Country Regression to Mean in Life Expectancy, 1960-2000
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Table 1: Evolution of Cross-Country Inequality in Income and Life Expectancy, 1960-2000 
     Income per Capita  Life Expectancy 
      1960  1990  2000    1960  1990  2000   
Relative Mean Dev   0.4751  0.4733  0.4215  0.1179 0.0507  0.0509 
Coeff of Variation   1.2344  1.2529  1.1662  0.2629 0.1245  0.1361 
Std Dev of Logs   1.0178  1.0300  0.9620  0.2552 0.1326  0.1513 
Gini Coeff    0.5104  0.5187  0.4873  0.1293 0.0690  0.0730 
Regression  to the Mean      -0.0069  -0.0741    -0.6133  0.0364 
over Previous Date 
    
(p-value=0.86) (p-value=0.00)   (p-value=0.00)  (p-value=0.31)
Note: Income per capita is GDP per capita in 1996 international prices, adjusted for terms of trade (Penn World Tables 6.1). Life 
expectancy is life expectancy at birth (World Development Indicators, World Bank). Inequality measures weighted by country 
population (abstracting from within country inequality). Sample includes 96 countries, comprising more than 82% of the world 
population. Regression to the mean is the coefficient of a regression of the change in the variable over the period on its initial level 




Table 2: Mean Life Expectancy at Birth of Countries in Various Ranges of National Income and Calorie 
Consumption, 1940 and 1970 
Daily  National Income per Capita in 1970 U.S. Dollars 
Calories           
Per Capita     < 150  150 - 299  300 - 699  > 700  All Income Levels 
< 2,100  1970  42.7  51.5  53.3  69.5  47.5 
  1940  38.3  36.0        37.9 
2,100 -2,399  1970  42.6  49.9  56.2  71.4  49.1 
 1940  40.0  43.9  46.1      43.4 
2,400 - 2,899  1970  45.4  57.9  61.3  68.0  61.4 
 1940      44.1  50.4  59.6  51.1 
> 2,900  1970        71.6  71.6 
  1940        58.7  65.2  64.0 
All Calories Levels  1970 42.7  52.4  57.8  70.8  55.9 
   1940  38.6  42.4  52.2  64.1  52.2 
Source: Preston (1980, Table 5.4, p.305). 
Note: 1970 countries appear in the top rows, 1940 countries in the bottom rows.   50





Disease  Approx. % of Mort. 
Decline in Less Dev 
Countries 
Accounted for 






Airborne  Influenza/ Pneumonia/ 
Bronchitis  30  
Antibiotics 
 Respiratory  tuberculosis  10  Immunization; identification 
and isolation 
Chemotherapy 
 Smallpox  2  Immunization  Chemotherapy 
 Measles  1  Immunization  Antibiotics 
 Diphtheria/Whooping  cough  2  Immunization Antibiotics 






7  Purification and increased 
supply of water; sewage 
disposal; personal sanitation 
Rehydration 
  Typhoid  1  Purification and increased 
supply of water; sewage 
disposal; personal sanitation; 
partially effective vaccine 
Rehydration, 
antibiotics 
  Cholera  1  Purification and increased 
supply of water; sewage 
disposal; personal sanitation; 
partially effective vaccine; 
quarantine 
Rehydration 
 Total  9     
Insect-borne Malaria  13-33  Insecticides, drainage, 
larvicides 
Quinine drugs 
 Typhus  1  Insecticides,  partially  effective 
vaccine 
Antibiotics 
 Plague  1  Insecticides,  rat  control, 
quarantine  
  Total 15-33    
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Table 4: Decomposition of Life Expectancy Gains by Cause of Death and Age Group, Regions of the World, 1965-1995 
 
Change in Life Expectancy  Europe & 
Cent. Asia 
E. Asia & 
Pacific 
Latin Am. & 
the Carib. 




 Total  8.6  5.4  10.2  18.0  5.8 
 Decomposition by Main Causes of Death:           
  Infectious 10%  7%  11%  0%  1% 
 
Nervous system and senses 
organs 
27% 26%  9%  1%  20% 
  Heart and circulatory  -2%  0%  -4%  -9%  39% 
  Respiratory and digestive  15%  19%  34%  67%  8% 
 
Congenit. Anomal. & perinatal 
cond. 
9% 19% 11%  14% 17% 
 Decomposition by Age Group:           
  Between 0 and 19  28%  41%  58%  90%  26% 
  Between 20 and 49  14%  7%  14%  5%  10% 
  50  and above  53%  49%  23%  3%  61% 
 
Note: Calculated from Table 4 in Becker et al (2005). Decomposition of life expectancy calculated by the authors based on age and cause specific 
mortality data from the World Health Organization. Regional averages weighted by country population. Sample includes 49 countries. 
 
 
Table 5: Age Specific Mortality Rates, World Regions 
Regions Mortality  rate, 
infant (p. 1,000 
live births)   
Mort. rate, under-
5 (p. 1,000 live 
births)   
Mortality rate, 
adult (per 1,000 
adults)   
   1960  2000    1960  2000    1960  2000    
Europe and Central Asia  45  16    56  20    160  165   
East Asia & Pacific  130  30    195  39    560  150   
Latin Am. & the Carib.  97  27    149  33    269  173   
Middle East & North Africa  157  41    252  50    299  165   
North America  26  7    30  8    177  111   
South Asia  145  70    243  96    425  228   
Sub-Saharan Africa  149  102    247  165    498  492   
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GDP)   
Hospital beds 
(per 1,000 




pop.)   
Access to 
treated water 
(% of pop.)   
    1990 2000  1990 2000  1960 1995  1990 2000  1990 2000  
Europe and 
Central  Asia 1.3  1.9  4.7  4.8  8.4  8.4  96  93  93  93   
East Asia & 
Pacific  1.5  2.8  2.0  2.0  3.9  3.3  36  47  72  77   
Latin Am. & 
the  Carib.  3.5  3.5  2.4  3.4  3.4  2.4  72  77  82  86   
Middle East 
& N. Africa  2.3  2.3  1.9  2.5  1.9  1.9  74  85  86  88   
North 
America  6.9  6.8  5.3  5.8  8.9  4.2  100 100  100 100  
South Asia 
3.3  3.7  0.9  1.0  0.5  0.5  22  34  72  84   
Sub-Saharan 
Africa  2.1  2.4  1.5  1.8  1.4  0.7  54  53  53  58  




Table 7: Inputs and other Indicators of Child Health, World Regions 
Regions  Immuniz., DPT (% 
of children < 1 
year)   
Immuniz., measles 
(% of child. < 1 
year)   
Low-birthweight 
babies (% of 
births)   
Malnutrition prev.   
(% of child. under 
5)   
   1980  2000    1980  2000    1980  1995    1985  1995   
Europe and 
Central Asia  77  94    54  90    5.9  7.0    ..  17.4   
East Asia & 
Pacific 38  85    34  86    11.8  10.8    42.5  31.0   
Latin Am. & the 
Carib. 43  87    47  92    8.0  9.3    24.7  18.5   
Middle East & 
North Africa  39 91    34 93    7.1  12.0    21.2  22.3   
North America 
96 95    93 92    6.6  7.2    .. 2.0   
South Asia 
8 61    2 56    22.4  31.2    60.1  49.9   
Sub-Saharan 
Africa 17  52    24  56    16.7  13.3    29.1  36.8   
Source: World Bank (2005).                  
 